Advertisement
Advertisement

ACET

ACET logo

Adicet Bio, Inc. Common Stock

8.55
USD
Sponsored
+0.23
+2.76%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

8.54

-0.01
-0.11%

Adicet Bio, Inc. Common Stock Profile

About

Adicet Bio Inc. is a biotechnology company. It engages in discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet Bio Inc., formerly known as RESTORBIO INC, is based in Calif.

Info & Links

CEO

Chen Schor

Headquarters

131 DARTMOUTH STREET, 3RD FLOOR
BOSTON, MA 02116, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.adicetbio.com

Auditor

KPMG LLP

Share holders

8

Employees

102

Adicet Bio, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

79.84M

Enterprise Value

41.92M

Enterprise Value/EBITDA(ttm)

-0.35

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.41

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-82.96%

Return on Invested Capital(ttm)

-84.44%

Return on Assets(ttm)

-68.00%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-119.78M

Net Income Available to Common(ttm)

-116.80M

Diluted EPS(ttm)

-17.98

Share Statistics

Beta (5Y Monthly)

1.57

52-Week Change

11.70%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

9.60M

Dividend Yield

0.00%

Float4

9.15M

% Held by Insiders

4.60%

% Held by Institutions

83.89%

Balance Sheet

Total Cash(mrq)

158.53M

Total Cash Per Share(mrq)

16.52

Total Debt(mrq)

991.00K

Total Debt/Equity(mrq)

0.62%

Current Ratio(mrq)

7.47%

Quick Ratio(mrq)

7.47%

Book Value Per Share(mrq)

16.61

Cash Flow

Operating Cash Flow Per Share(ytd)

-13.82

Free Cash Flow(ytd)

-96.98M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement